Biology

Succeeding in the 2020 US Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Biology, Life sciences, Biotechnology, Medical tests, Microarrays, Molecular diagnostics, Agilent Technologies, Biochip

Succeeding in the 2020 US Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

Key Points: 
  • Succeeding in the 2020 US Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
    This new 1157-page report contains 65 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including:
    Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:

Succeeding in the 2020 POC Hematology and Flow Cytometry Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Biology, Cell biology, Clinical pathology, Laboratory techniques, Blood tests, Medical tests, Flow cytometry, Cytometry, Marketing strategy, Marketing

Succeeding in the 2020 POC Hematology and Flow Cytometry Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities

Key Points: 
  • Succeeding in the 2020 POC Hematology and Flow Cytometry Market: Future Horizons and Growth Strategies--Supplier Shares, Competitive Intelligence, Emerging Opportunities
    This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
  • This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market.

With Over 280 Therapies Under Evaluation, the Stem Cell Therapy Market is Estimated to be Worth USD 8.5 Billion by 2030, Claims Roots Analysis

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cloning, Developmental biology

It is worth highlighting that the abovementioned therapies are designed to treat musculoskeletal (22%), neurological (21%) and cardiovascular (15%) disorders.

Key Points: 
  • It is worth highlighting that the abovementioned therapies are designed to treat musculoskeletal (22%), neurological (21%) and cardiovascular (15%) disorders.
  • Within these regions, the US, China, South Korea and Japan, have emerged as key R&D hubs for stem cell therapies.
  • The stem cell therapies market is anticipated to witness an annualized growth rate of over 30% during the next decade.
  • The USD 8.5 billion (by 2030) financial opportunity within the stem cell therapies market has been analyzed across the following segments:

New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Molecular biology, Omics, Transcriptomics technologies, Biology, Intensive care medicine, Neuroscience, Procalcitonin

The molecular classifier used in the study forms the basis of Inflammatix's HostDx rapid tests, which the company is developing to overcome traditional challenges of diagnosing acute infections and sepsis.

Key Points: 
  • The molecular classifier used in the study forms the basis of Inflammatix's HostDx rapid tests, which the company is developing to overcome traditional challenges of diagnosing acute infections and sepsis.
  • "For 20 years, researchers have been looking for a way to use transcriptomics the study of the body's gene expression to classify patients with acute infections.
  • To date, others' attempts to apply machine learning to this problem have not held up when applied to diverse patient populations.
  • Our new study is the first time that a locked, multi-gene signature has been validated in a blinded, independent clinical cohort.

Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine using STARR Technology™

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Biology, Biotechnology, Vaccines, Vaccination, Arcturus Therapeutics, Vaccine, Messenger RNA, Zika virus vaccine, H5N1 vaccine

Due to superior immune response and sustained protein expression, Arcturus STARR Technology is expected to produce a vaccine response at much lower doses compared to traditional mRNA vaccines.

Key Points: 
  • Due to superior immune response and sustained protein expression, Arcturus STARR Technology is expected to produce a vaccine response at much lower doses compared to traditional mRNA vaccines.
  • We have observed STARR technology in pre-clinical models to be effective at extraordinarily low doses -- greater than 30-fold more efficient than traditional mRNA.
  • If successful, Arcturus could develop a vaccine capable of vaccinating millions of people for a fraction of the cost of traditional mRNA vaccines, said Joseph Payne, President & CEO of Arcturus Therapeutics.
  • Arcturus plans to apply its STARR Technology toward the development of a vaccine to protect against COVID-19.

 Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19

Retrieved on: 
Wednesday, March 4, 2020
Technology, Research, Infectious diseases, Other Technology, Clinical trials, Biotechnology, Health, Pharmaceutical, Science, Branches of biology, RNA, Biology, Biotechnology, Alnylam Pharmaceuticals, Therapeutic gene modulation, Gene expression, Coronaviridae, Small interfering RNA, RNA interference, Coronavirus, RNAi, Vir Biotechnology, Alnylam

The collaboration will focus on development of siRNAs that Alnylam recently identified that target highly conserved regions of coronavirus RNAs.

Key Points: 
  • The collaboration will focus on development of siRNAs that Alnylam recently identified that target highly conserved regions of coronavirus RNAs.
  • Alternatively, Alnylam may elect to earn development and commercialization milestones and royalties on net sales of products resulting from the collaboration in amounts agreed upon for the coronavirus program.
  • RNAi is a powerful, natural cellular mechanism that can be harnessed to develop a broad range of innovative medicines, including anti-viral therapies.
  • As the leader in RNAi therapeutics, we at Alnylam are committed to doing our part in joining other biopharmaceutical companies, like Vir, to address this emerging outbreak.

Genomics Market Size Worth $31.1 Billion by 2027 | CAGR: 7.7%: Grand View Research, Inc.

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Medicine, Biology, Biotechnology, Emerging technologies, 23andMe, Genomics, Personalized medicine

SAN FRANCISCO, March 4, 2020 /PRNewswire/ -- The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, March 4, 2020 /PRNewswire/ -- The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc.
  • Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market.
  • Key suggestions from the report:
    Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.
  • Grand View Research has segmented the global genomics market on the basis of deliverables, application and technology, end use, and region:

Genomics Market Size Worth $31.1 Billion by 2027 | CAGR: 7.7%: Grand View Research, Inc.

Retrieved on: 
Wednesday, March 4, 2020
Branches of biology, Medicine, Biology, Biotechnology, Emerging technologies, 23andMe, Genomics, Personalized medicine

SAN FRANCISCO, March 4, 2020 /PRNewswire/ -- The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, March 4, 2020 /PRNewswire/ -- The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc.
  • Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market.
  • Key suggestions from the report:
    Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.
  • Grand View Research has segmented the global genomics market on the basis of deliverables, application and technology, end use, and region:

Researchers Find Gene Variants that May Increase Susceptibility to Alzheimer's Proteins

Retrieved on: 
Tuesday, March 3, 2020
Proteins, Tau protein, Branches of biology, Dementia, Psychiatric diagnosis, Alzheimer's disease, Biology, Cognitive disorders, Neuroscience

But until now they have struggled to understand what factors make you more or less likely to develop these tangles.

Key Points: 
  • But until now they have struggled to understand what factors make you more or less likely to develop these tangles.
  • The researchers found that people with certain gene variants on chromosomes 1 and 5 had a higher amount of tau in their brains than the people who had the more typical gene sequences in those regions.
  • The gene variants were found in around 2 to 3% of the group, and those with the variants had about 10% higher tau levels than those without.
  • For more information about the American Academy of Neurology, visit AAN.com or find us on Facebook , Twitter , Instagram , LinkedIn and YouTube .

Forged Documents, Counterfeit Goods, Cyber Intrusion Including Identity Theft Have Become a Symbol Of Our 21st Century Culture

Retrieved on: 
Tuesday, March 3, 2020
Biology, Gender, Identity, Nefarious

There is no boundary to age, gender, income level or status in the community.

Key Points: 
  • There is no boundary to age, gender, income level or status in the community.
  • If you find yourself on the call list for some unscrupulous character here are some things you should be aware of.
  • This is partly due to the fact that many of these nefarious individuals and organizations are not domiciled here in Canada.
  • We truly hope you do not need our services, but if you do, you can count on us to assist with establishing your true identity.